A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

NCT07743450 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1560

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight
Chronic Weight Management
Type 2 Diabetes Mellitus

Interventions

DRUG: ASC30 tablets A1
DRUG: Placebo

Sponsor

Ascletis Pharma (China) Co., Limited